RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make a poster presentation at the 22nd International Conference on Antiviral Research. The poster will be given by PolyMedix Scientific Advisor Dr. David Miller, on Tuesday, May 5, at the Miami Beach Resort & Spa in Florida. In addition, PolyMedix was one of a select few companies invited to orally present their results. This oral presentation will occur on Thursday, May 7 at 11am.
